Oramed Pharmaceuticals
ORMP
#9144
Rank
ยฃ0.14 B
Marketcap
ยฃ3.47
Share price
0.21%
Change (1 day)
103.17%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2026 (TTM): ยฃ58.3 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of ยฃ57.78 Million, an increase over its 2024 earnings that were of -ยฃ11.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) ยฃ58.3 M0.88%
2025 ยฃ57.78 M-616.9%
2024 -ยฃ11.18 Million-311.47%
2023 ยฃ5.28 M-119.45%
2022 -ยฃ27.18 Million39.17%
2021 -ยฃ19.53 Million73.93%
2020 -ยฃ11.23 Million18.53%
2019 -ยฃ9.48 Million-16.62%
2018 -ยฃ11.37 Million38.32%
2017 -ยฃ8.22 Million12.51%
2016 -ยฃ7.3 Million25.01%
2015 -ยฃ5.84 Million18.18%
2014 -ยฃ4.95 Million39.72%
2013 -ยฃ3.54 Million46.4%
2012 -ยฃ2.42 Million128.32%
2011 -ยฃ1.06 Million-51.47%
2010 -ยฃ2.19 Million35.21%
2009 -ยฃ1.62 Million
2007 -ยฃ2.54 Million607.04%
2006 -ยฃ0.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
ยฃ18.55 B 31,672.04%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
ยฃ5.68 B 9,628.39%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-ยฃ0.4 Billion-781.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-ยฃ19.36 Million-133.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
ยฃ25.88 M-55.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel